Dr Jocalyn Clark, most recently of The Lancet, will be The BMJ‘s new international editor. Dr Clark has a passion for equity, diversity, and inclusion in medicine and global health, and will take up her post in August 2022.
She has proven expertise and leadership in advancing action on the social determinants of health and climate change, gender equality, and delivering evidence-based content, policy, and strategy across international editorial environments.
Since March 2016, Dr Clark has been an Executive Editor of The Lancet where she led the journal’s Comment section, helped set strategy for global health and commissioning, and was responsible for peer review and diversifying the journal’s commentary and research. Dr Clark also led #LancetWomen to advance women in science, medicine, and global health, which also saw the journal improve the gender and geographic balance of its reviewers, authors, and editorial advisors.
Previously she was Executive Editor (2013-16) at the global health research organisation icddr,b in Dhaka, Bangladesh, and from 2008-2013, she globalised journal content and strategy as Senior Editor at PLOS Medicine. Across her career, Dr Clark has developed and edited high-impact content in areas including maternal and child health, sexual and reproductive health and rights, migration and humanitarianism, global oral health, and death and dying.
In 2019 she was elected to the Royal College of Physicians of Edinburgh and the Canadian Academy of Health Sciences for her role in advancing international perspectives and gender equity in health.
She is also an advisor to Global Health 50/50 and WomenLift Health, Chair of the Governance Council of the Canadian Medical Association Journal, and a member of the WHO Research Group on Health Statistics.
For Dr Clark, this new role marks a return to The BMJ, where she was Editorial Registrar and Assistant then Associate Editor from 2002-2007.
Click here to read the original press release.
